LLSR
News:
June 10 - Lantis Laser Commences Phase 3 Development of it's OCT Light-Based Dental Imaging System
Eclipse Product Development Selected for Design, Interface and Documentation Phase
Lantis Laser Inc. (OTC: LLSR) (www.lantislaser.com) announced that it has commenced Phase 3 of the development cycle of its proprietary, highly advanced Optical Coherence Tomography (OCT) Dental Imaging System™. The OCT System is a diagnostic light-based, chairside, system that images in real-time at a resolution of to 10 times x-ray and without any harmful radiation. It is expected to have a major impact on early diagnostics and the advancement of minimally invasive treatment once it is deployed in dental offices.
“Phase 3 development embodies a number of significant events in the evolution of OCT for dentistry,” said Stan Baron, president and CEO of Lantis. “The components of the OCT System that needed to be upgraded to meet the requirements of the fast scanning speed enabled by AXSUN Technologies swept source laser, are being readied for integration into the OCT Beta Systems. We expect to deploy the Beta Systems for clinical use in the July/August timeframe.”
Phase 3 of the product development cycle also requires that the OCT System’s mobile cart will be designed, that the user interface be refined and that documentation in preparation for the FDA filing be prepared. After an extensive review of product design companies, Lantis is pleased to announce that it has selected Eclipse Product Development to undertake this demanding task.
Vice President of Research and Development at Lantis, Doug Hamilton, commented, “OCT is not a modality that many companies have had experience with, so we looked for a company that had a solid industrial design core and the network to bring in the best available resources for each discipline that is deployed in the OCT System. Eclipse provides us with this development model and the flexibility we need to complete this Phase in an efficient and timely manner.”
“All the components leading to up to FDA submission, manufacturing and marketing are now being put into place,” said Baron. “We will be making regular announcements as we progress to keep the investment and dental community abreast of developments”.
ABOUT ECLIPSE PRODUCT DEVELOPMENT
Eclipse, located in Amesbury, MA has over 13 years of experience helping clients commercialize medical, laboratory and dental category technologies. The company is medically oriented and has designed numerous products including complex diagnostic and therapeutic medical and dental equipment and devices. Their development process meets FDA and ISO requirements for design control documentation and verification. Eclipse has developed a strategic business model to include several experienced molding and manufacturing vendor relationships. |
